GlassScriptPhysician profile
Joel B Nilsson
NPI 1487633384
$1,223.57
in general payments reported to CMS, 2019-2025
19 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $212 · 2021: $124 · 2022: $83.41 · 2023: $39.32 · 2024: $430 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $364.70 | 2019-2024 | Mako, Actishield, Insignia |
| Heron Therapeutics, INC. | $179.94 | 2021-2024 | Zynrelef |
| Ermi LLC | $129.67 | 2019-2021 | |
| Acumed LLC | $84.41 | 2025 | Acumed |
| Endo Pharmaceuticals INC. | $70.92 | 2019-2021 | |
| Anika Therapeutics, INC. | $47.74 | 2022-2023 | Ovomotion, Twist, Total Anika |
| Smith+Nephew, INC. | $43.39 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $43.22 | 2019-2020 | |
| Endo USA, INC. | $42.02 | 2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $27.78 | 2025 | |
| Depuy Synthes Sales INC. | $26.85 | 2025 | Speed |
| Orthofix Medical, INC. | $25.00 | 2019-2020 | |
| Abbott Laboratories | $22.27 | 2019 | |
| Davol INC. | $21.21 | 2024 | Arista Ah Flexitip |
| Vericel Corporation | $20.48 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $20.02 | 2024 | Sx-One Microknife |
| Ultragenyx Pharmaceutical INC. | $18.23 | 2019 | |
| Si-Bone, INC. | $18.04 | 2020 | |
| Arthrosurface Incorporated | $17.68 | 2025 | Hemicap, Hemicapovo, Revomotion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Nilsson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.